Extendicare Inc. (EXETF)
OTCMKTS · Delayed Price · Currency is USD
9.44
-0.18 (-1.87%)
Jul 18, 2025, 4:00 PM EDT
Extendicare Revenue
Extendicare had revenue of 374.65M CAD in the quarter ending March 31, 2025, with 2.06% growth. This brings the company's revenue in the last twelve months to 1.47B, up 9.38% year-over-year. In the year 2024, Extendicare had annual revenue of 1.47B with 12.36% growth.
Revenue (ttm)
1.47B CAD
Revenue Growth
+9.38%
P/S Ratio
0.77
Revenue / Employee
62.71K CAD
Employees
23,500
Market Cap
788.52M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo, Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 84.04M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.70M |
Extendicare News
- 13 days ago - Extendicare Announces Timing of 2025 Second Quarter Results and Conference Call - GlobeNewsWire
- 18 days ago - Extendicare Acquires Closing the Gap Healthcare Group - GlobeNewsWire
- 24 days ago - Extendicare Announces Renewal of Normal Course Issuer Bid - GlobeNewsWire
- 4 weeks ago - Extendicare Inc. declares CAD 0.042 dividend - Seeking Alpha
- 6 weeks ago - Extendicare Acquires Nine Long-Term Care Homes from Revera - GlobeNewsWire
- 7 weeks ago - Extendicare Announces Voting Results for its 2025 Annual and Special Meeting of Shareholders - GlobeNewsWire
- 7 weeks ago - Kyle Taylor's top stock picks: Spotify and Extendicare - BNN Bloomberg
- 2 months ago - Extendicare Inc. 2025 Q1 - Results - Earnings Call Presentation - Seeking Alpha